EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease

Neha Bhat, Arya Mani

Nutrients · 16.05.2023 · 15 (10) · 2323

DOI: 10.3390/nu15102323 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 16.05.2023. Verfasst von Neha Bhat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06511, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-Alcoholic Fatty Liver Disease (NAFLD) is a highly prevalent condition affecting approximately a quarter of the global population. It is associated with increased morbidity, mortality, economic burden, and healthcare costs. The disease is characterized by the accumulation of lipids in the liver, known as steatosis, which can progress to more severe stages such as steatohepatitis, fibrosis, cirrhosis, and even hepatocellular carcinoma (HCC). This review focuses on the mechanisms that contribute to the development of diet-induced steatosis in an insulin-resistant liver. Specifically, it discusses the existing literature on carbon flux through glycolysis, ketogenesis, TCA (Tricarboxylic Acid Cycle), and fatty acid synthesis pathways in NAFLD, as well as the altered canonical insulin signaling and genetic predispositions that lead to the accumulation of diet-induced hepatic fat. Finally, the review discusses the current therapeutic efforts that aim to ameliorate various pathologies associated with NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCarcinoma, HepatocellularLiver NeoplasmsHumansLiverFibrosisInsulinLipidsGlucoseLipid Metabolism

Stichwörter der Autor:innen

NAFLDinsulin resistancelipid metabolismsubstrate fluxtype II diabetes

Substanzen

InsulinLipidsGlucose

Autor:innen und Institutionen

  • Cardiovascular Research Center, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06511, USA.

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bhat, N., & Mani, A. (2023). Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease. Nutrients, 15(10), 2323. https://doi.org/10.3390/nu15102323

Vancouver

Bhat N, Mani A. Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease. Nutrients. 2023;15(10):2323. doi:10.3390/nu15102323

BibTeX
@article{Bhat2023,
  author = {Bhat, Neha and Mani, Arya},
  title = {Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {10},
  pages = {2323},
  doi = {10.3390/nu15102323}
}
Kostenlos starten →